BIO: Corporate Governance Report (first 06 months)
BIO: Result of transactions of Directors, PDMR (Nguyen Thanh Long)
With risks from interruption of the medical ingredient supply chain and losses in the hospital channel, the Vietnamese pharma industry experienced a topsy-turvy first half of 2021, with potential growth set to focus on mergers and acquisitions.